Telangana, India

Hari Prasad Kokatla


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hari Prasad Kokatla

Introduction

Hari Prasad Kokatla is a notable inventor based in Telangana, India. He has made significant contributions to the field of therapeutic compounds, particularly through his innovative work on Toll-like receptor 8 (TLR8) agonists. His research focuses on developing compounds that can be utilized for various therapeutic purposes, showcasing his commitment to advancing medical science.

Latest Patents

Hari Prasad Kokatla holds a patent for "Toll-like receptor 8 agonists." The compounds described in this patent can be used for therapeutic purposes, particularly as TLR agonists. These compounds can be included in pharmaceutical compositions and are useful in therapies where being a TLR8 agonist is beneficial. The pharmaceutical compositions may contain various ingredients, such as carriers, diluents, excipients, fillers, or other common components found in pharmaceutical formulations. The compounds can include those illustrated or described in the patent, as well as their derivatives, prodrugs, salts, stereoisomers, tautomers, polymorphs, solvates, or combinations thereof. These compounds can also serve as adjuvants in vaccines and for other therapeutic applications.

Career Highlights

Hari Prasad Kokatla is affiliated with the University of Kansas Medical Center Research Institute. His work at this esteemed institution has allowed him to explore and develop innovative therapeutic solutions. His dedication to research and development has positioned him as a valuable contributor to the scientific community.

Collaborations

Hari Prasad Kokatla has collaborated with notable colleagues, including Sunil Abraham David and Diptesh Sil. These collaborations have further enriched his research endeavors and have contributed to the advancement of therapeutic innovations.

Conclusion

In summary, Hari Prasad Kokatla is an accomplished inventor whose work on TLR8 agonists has the potential to significantly impact therapeutic practices. His contributions to the field of medicine exemplify the importance of innovation in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…